Although the involvement of ENTPD2 in obesity or metabolic dysregulation remains poorly characterized, the integrative transcriptomic and lipidomic analysis of eWAT identified ENTPD2 as a key DEG potentially involved in adipose tissue regulation. Here, ENTPD2 is linked to obesity disorder.